A critical aspect of a synthetic minimal cell is expansion of the surrounding boundary layer. This layer should consist of phospholipids (mimics) as these molecules assemble into a bilayer, creating a functional barrier with specific phospholipid species that are essential for membrane related processes. As a first step towards synthetic cells, an in vitro phospholipid biosynthesis pathway has been constructed that utilizes fatty acids as precursors to produce a wide variety of phospholipid species, thereby driving membrane growth. This now needs to be developed further into a sustainable expanding system, meanwhile keeping simplicity in mind. The non-enzymatic synthesis of phospholipid-like molecules forms a realistic alternative for natural enzymatic-based pathways, that nowadays can even support functional membrane proteins. Eventually, coupling to in vitro transcription/translation is required, for which efficient mechanisms of insertion and folding of the involved membrane proteins need to be developed. Such an integrated system will form a suitable foundation of a synthetic minimal cell that eventually can be coupled to other cellular processes such as division.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1042/ETLS20190020 | DOI Listing |
Biomater Sci
January 2025
School of Chemistry and Life Sciences, Hanoi University of Science and Technology, 1 Dai Co Viet Road, Ha Noi, Vietnam.
With the advancement of photodynamic therapy, various photosensitizers have been developed to enhance the efficacy of cancer treatment while minimizing side effects. Recently, near-infrared organic fluorophores have gained significant attention as promising photodynamic agents for cancer therapy due to their tunable photophysical properties, structural versatility, good biocompatibility, high biosafety, and synthetic flexibility. In particular, near-infrared organic photosensitizers offer several notable advantages, including deep tissue penetration, a low fluorescence background for bioimaging, and reduced damage to biological tissues compared to traditional visible-spectrum photosensitizers.
View Article and Find Full Text PDFOne Health
June 2025
Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University, Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA.
Controlling insect pests that destroy crop and spread diseases will become increasingly crucial for addressing the food demands of a growing global population and the expansion of vector-borne diseases. A key challenge is the development of a balanced approach for sustainable food production and disease control in 2050 and beyond. Microbial biopesticides, derived from bacteria, viruses, fungi, protozoa, or nematodes, offer potentially significant benefits for promoting One Health and contributing to several United Nations Sustainable Development Goals (SDGs).
View Article and Find Full Text PDFFront Allergy
January 2025
Schmid College of Science and Technology, Chapman University, Orange, CA, United States.
Detection canines can identify numerous substances for which they have been trained. Historically, and a point of ongoing contention, detection canine threshold (i.e.
View Article and Find Full Text PDFArch Insect Biochem Physiol
January 2025
Department of Entomology, College of Plant Protection, China Agricultural University, Beijing, China.
Cyclaniliprole, a type of the third-generation anthranilic diamide insecticide, was mainly used for management of various pests. Myzus persicae (Hemiptera: Aphididae), known as the peach-potato aphid, is an economically essential pest with worldwide distribution. However, the risk assessment of cyclaniliprole in M.
View Article and Find Full Text PDFInt J Biol Macromol
January 2025
Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address:
Intratumoral drug delivery systems hold immense promise in overcoming the limitations of conventional IV chemotherapy, particularly in enhancing therapeutic efficacy and minimizing systemic side effects. In this study, we introduce a novel redox-responsive intratumoral nanogel system that combines the biocompatibility of natural polysaccharides with the tailored properties of synthetic polymers. The nanogel features a unique cross-linked architecture incorporating redox-sensitive segments, designed to leverage the elevated glutathione levels in the tumor microenvironment for controlled drug release.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!